Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
Clinical trial NCT03090139 · COMPLETED
Trial details
- NCT number
- NCT03090139
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-28
- Primary completion
- 2018-06-13
- Enrollment
- 1731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.